✦ Summary ✦I am recognized for driving financial growth and spearheading scalable initiatives that enhance operational efficiencies within multinational Fortune 250 enterprises. My approach consistently emphasizes cultivating a culture that values ongoing enhancement and leadership skills development.With over 15 years of rich experience, I've honed my expertise in strategic planning, executive leadership, business expansion, and comprehensive financial management within complex, globally distributed organizations. My role extends beyond steering the company's strategic direction—it's about ensuring our path forward aligns seamlessly with our goals for growth and superior operational performance.✦ Areas of Expertise ✦Financial Analytics | Financial Planning | Budget Management | Investment Analysis | Financial Control | Regulatory Compliance | Corporate Tax Knowledge | Operational Scaling | Risk Management | Process Automation | Change Leadership | Strategic Partnerships | Talent Development | Stakeholder Management | Organizational Design | M&A Expertise | Commercial Strategy | Global Leadership | International Finance | Capital Management✦ Key Achievements ✦• Internal Controls Oversight, Medela: Orchestrated the establishment of a robust internal control system, effectively bridging a significant accounting control gap in the US.• Organizational Restructuring, Medela: Directed a sweeping organizational restructuring initiative, resulting in the elimination of approximately 50 positions and realizing $5M in annual operational expense savings, thereby augmenting overall profitability and operational efficiency.• Process Automation Leadership, Medela: Championed the implementation of automated invoice processing, markedly reducing manual workload and enhancing operational efficiency.• Investment Strategy Execution, Baxter: Guided intricate financial modeling and achieved consensus among stakeholders for Board-level investment proposals, including a pivotal $200M US manufacturing expansion and a strategic $100M investment in China, instrumental for future compliance and business success. • Financial Leadership and Transition Management, Baxter: Successfully led the financial transition of the US Biosurgery business during Baxter's division into Baxter and Baxalta in July 2015, managing financial aspects and seamlessly integrating assets, processes, and personnel, while adeptly handling HR-related challenges associated with the company split.Please feel free to contact me at nathan.berg@hotmail.com!